Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Sangamo Biotech a Strong Buy
Oct 10, 2008 03:31 PM
- Analyst Comments: Sangamo Bioscience, CryoLife, Progressive, EnCana, Linear Tech, Cosi
Jul 11, 2008 02:24 PM
- Jobless Claims, Oil Prices & Healthcare
Jun 19, 2008 10:24 AM
- Analyst Comments: Lithia, Exar, OPNET, Sangamo, Baxter, Castle Brands
Apr 22, 2008 10:02 AM
- Analyst Comments: Sangamo Biosciences, Hitachi, Allot Communications, Philips
Feb 06, 2008 01:26 PM
- Intrepid Makes First FiberBlend(TM) Sale to Major Soil Amendment and Aggregate Company and Flotek Industries, Inc. Issues 2008 Financial Guidance
Feb 06, 2008 09:29 AM
- Retail Sales, Subprime, Rates & Jobs
Dec 06, 2007 10:14 AM
- Rh-Apo2L Named as One of China's High-Tech Transforming Products by Chinese Government and National Cancer Institute Study to Determine the Optimal Time for CLL Patients to Begin Treatment
Dec 05, 2007 09:58 AM
- Pfizer Inc Commences Tender Offer for All Outstanding Shares of Coley Pharmaceutical Group, Inc. and Lenalidomide (REVLIMID(R)) Receives Orphan Medicinal Product Designation from the European Commission for Chronic Lymphocytic Leukemia
Dec 03, 2007 09:28 AM
- CytRx Reports Third Quarter 2007 Financial Results and Sangamo BioSciences VP Exercises Options
Nov 15, 2007 09:28 AM
- Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
Nov 25, 2008 04:05 PM
- Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Nov 19, 2008 04:05 PM
- Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
Nov 10, 2008 04:02 PM
- Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Oct 29, 2008 04:06 PM
- Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
Oct 28, 2008 04:05 PM
- Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
Oct 22, 2008 04:00 PM
- Zacks Analyst Blog Highlights: Everest Re Group, Ltd., State Auto Financial Corp., Sangamo Biosciences, Inc., Lloyds TSB Group Plc. And HBOS Plc.
Oct 13, 2008 01:11 AM
- Zacks Bull and Bear of the Day Highlights: St. Jude Medical, AAR Corp., Sangamo Biosciences, State Auto Financial and Robert Half
Oct 10, 2008 12:17 AM
- Sangamo BioSciences to Present at Two Upcoming Investor Conferences
Sep 29, 2008 04:00 PM
- Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
Sep 16, 2008 05:59 PM
- Form 3 Cleveland Paul B For: Nov 19 (10K)
Nov 21, 2008 08:00 PM
- Form 4 Cleveland Paul B For: Nov 19 (10K)
Nov 21, 2008 07:58 PM
- Form 4 SANGAMO BIOSCIENCES INC For: Sep 02 Filed by: Gregory Philip D (10K)
Sep 04, 2008 10:50 PM
- Form 4 SANGAMO BIOSCIENCES INC For: Aug 15 Filed by: LANPHIER EDWARD O II (10K)
Aug 19, 2008 10:51 PM
- Form 4 SANGAMO BIOSCIENCES INC For: Aug 15 Filed by: Gregory Philip D (10K)
Aug 19, 2008 10:31 PM
- Form 4 LARSON JOHN WILLIAM For: Jul 31 (10K)
Aug 01, 2008 06:45 PM
- Form 4 LARSON JOHN WILLIAM For: Jul 29 (10K)
Jul 31, 2008 08:39 PM
- Form 4 SANGAMO BIOSCIENCES INC For: Jul 15 Filed by: LANPHIER EDWARD O II (10K)
Jul 17, 2008 09:31 PM
- Form 4 Gregory Philip D For: Jul 01 (10K)
Jul 03, 2008 04:33 PM
- Form 4 LANPHIER EDWARD O II For: Jun 30 (10K)
Jul 02, 2008 09:32 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
SGMO
|
Compare to S&P
|
| YTD |
-81.11 %
|
-69.05 %
|
| 4 Weeks |
-68.50 %
|
-65.95 %
|
| 12 Weeks |
-74.19 %
|
-64.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 16.67 %
|
|
EPS Growth in Last Year: -36.36 %
|
|
Sales Growth in Last Quarter: 31.77 %
|
|
Sales Growth in Last Quarter: 61.08 %
|
|
|
